Published in J Virol on October 01, 2000
Mouse mammary tumor virus encodes a self-regulatory RNA export protein and is a complex retrovirus. J Virol (2005) 1.36
The type B leukemogenic virus truncated superantigen is dispensable for T-cell lymphomagenesis. J Virol (2003) 0.95
Endogenous MMTV proviruses induce susceptibility to both viral and bacterial pathogens. PLoS Pathog (2006) 0.93
The homeodomain protein CDP regulates mammary-specific gene transcription and tumorigenesis. Mol Cell Biol (2004) 0.90
Conversion of mouse mammary tumor virus to a lymphomagenic virus. J Virol (2005) 0.86
Cross-packaging of genetically distinct mouse and primate retroviral RNAs. Retrovirology (2009) 0.82
Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu Rev Immunol (1991) 5.71
Complete nucleotide sequence of a milk-transmitted mouse mammary tumor virus: two frameshift suppression events are required for translation of gag and pol. J Virol (1987) 4.37
Endogenous mammary tumour virus DNA varies among wild mice and segregates during inbreeding. Nature (1979) 3.15
A maternally inherited superantigen encoded by a mammary tumour virus. Nature (1991) 2.92
Clonal deletion of V beta 14-bearing T cells in mice transgenic for mammary tumour virus. Nature (1991) 2.76
Foamy viruses are unconventional retroviruses. J Virol (1999) 2.71
Transgenic mouse mammary tumor virus superantigen expression prevents viral infection. Cell (1992) 2.55
Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyte. Gene (1990) 2.22
Superantigen-induced immune stimulation amplifies mouse mammary tumor virus infection and allows virus transmission. Cell (1993) 2.11
Construction of a clonable, infectious, and tumorigenic mouse mammary tumor virus provirus and a derivative genetic vector. Proc Natl Acad Sci U S A (1988) 1.73
A standardized nomenclature for endogenous mouse mammary tumor viruses. J Virol (1987) 1.65
B cells are essential for murine mammary tumor virus transmission, but not for presentation of endogenous superantigens. J Exp Med (1994) 1.56
Structural analysis of a 1.7-kilobase mouse mammary tumor virus-specific RNA. J Virol (1983) 1.55
Transcription of mouse mammary tumor virus: identification of a candidate mRNA for the long terminal repeat gene product. J Virol (1983) 1.43
Mouse mammary tumor virus proviruses in T-cell lymphomas lack a negative regulatory element in the long terminal repeat. J Virol (1988) 1.42
Phylogenetic and structural analyses of MMTV LTR ORF sequences of exogenous and endogenous origins. Virology (1993) 1.36
B and T cells are required for mouse mammary tumor virus spread within the mammary gland. J Immunol (1998) 1.33
Generation of a tumorigenic milk-borne mouse mammary tumor virus by recombination between endogenous and exogenous viruses. J Virol (1997) 1.27
The mouse mammary tumour virus long terminal repeat encodes a type II transmembrane glycoprotein. EMBO J (1992) 1.25
Structural analysis of a mouse mammary tumor virus superantigen. J Exp Med (1992) 1.24
Direct evidence for the role of COOH terminus of mouse mammary tumor virus superantigen in determining T cell receptor V beta specificity. J Exp Med (1993) 1.12
Homeoproteins CDP and SATB1 interact: potential for tissue-specific regulation. Mol Cell Biol (1999) 1.10
Endogenous superantigen expression controlled by a novel promoter in the MMTV long terminal repeat. Nature (1993) 1.09
Phorbol diester-inducible, cyclosporine-suppressible transcription from a novel promoter within the mouse mammary tumor virus env gene. J Virol (1988) 1.08
A redundant nuclear protein binding site contributes to negative regulation of the mouse mammary tumor virus long terminal repeat. J Virol (1995) 1.07
Mutational and functional analysis of the C-terminal region of the C3H mouse mammary tumor virus superantigen. J Virol (1998) 1.03
An activation-dependent, T-lymphocyte-specific transcriptional activator in the mouse mammary tumor virus env gene. Mol Cell Biol (1992) 1.02
Identification and functional characterization of a high-affinity Bel-1 DNA binding site located in the human foamy virus internal promoter. J Virol (1998) 1.02
Rev/RRE-independent Mason-Pfizer monkey virus constitutive transport element-dependent propagation of SIVmac239 vectors using a single round of replication assay. Virology (1996) 1.00
Mouse mammary tumor viruses with functional superantigen genes are selected during in vivo infection. Proc Natl Acad Sci U S A (1995) 0.99
Exogenous mouse mammary tumor virus (MMTV) infection induces endogenous MMTV sag expression. Virology (1996) 0.94
Structure and biological activity of the subgenomic Mtv-6 endogenous provirus. Virology (1995) 0.93
Transposon-mediated random insertions and site-directed mutagenesis prevent the trafficking of a mouse mammary tumor virus superantigen. Virology (1998) 0.90
Tissue-specific expression of messenger RNAs encoding endogenous viral superantigens. J Immunol (1994) 0.88
Mouse mammary tumor virus superantigen expression in B cells is regulated by a central enhancer within the pol gene. J Virol (1998) 0.87
Strain-specific expression of spliced MMTV RNAs containing the superantigen gene. Virology (1997) 0.87
Shared promoter elements between a viral superantigen and the major histocompatibility complex class II-associated invariant chain. J Virol (1997) 0.85
Stimulation of mouse mammary tumor virus superantigen expression by an intragenic enhancer. Proc Natl Acad Sci U S A (1995) 0.85
Interactions of a transcriptional activator in the env gene of the mouse mammary tumor virus with activation-dependent, T cell-specific transacting factors. J Biol Chem (1996) 0.83
Expression of mouse mammary tumor virus superantigen mRNA in the thymus correlates with kinetics of self-reactive T-cell loss. J Virol (1999) 0.83
Immune response to mouse mammary tumor virus in mice lacking the alpha/beta interferon or the gamma interferon receptor. J Virol (1998) 0.80
Mouse mammary tumor virus superantigens require N-linked glycosylation for effective presentation to T cells. Virology (1997) 0.80
Transgenic mouse mammary tumor virus superantigen expression prevents viral infection. Cell (1992) 2.55
Seroconversion, sexual activity, and condom use among 2915 HIV seronegative men followed for up to 2 years. J Acquir Immune Defic Syndr (1989) 2.48
Sales of nonprescription cold remedies: a unique method of influenza surveillance. Pediatr Res (1979) 2.22
Engraftment syndrome after auto-SCT: analysis of diagnostic criteria and risk factors in a large series from a single center. Bone Marrow Transplant (2010) 1.52
The matrix attachment region-binding protein SATB1 participates in negative regulation of tissue-specific gene expression. Mol Cell Biol (1997) 1.50
Variations in the electrocardiograms of young adults: are revised criteria for thrombolysis needed? Acad Emerg Med (1995) 1.43
West Nile Virus in the New World: trends in the spread and proliferation of West Nile Virus in the Western Hemisphere. Zoonoses Public Health (2009) 1.39
[ABO incompatible living donor kidney transplantation: a dream come true. Experience of Hospital Clínic of Barcelona]. Nefrologia (2009) 1.37
A massive, cooling-flow-induced starburst in the core of a luminous cluster of galaxies. Nature (2012) 1.36
B and T cells are required for mouse mammary tumor virus spread within the mammary gland. J Immunol (1998) 1.33
Purification and translation of murine mammary tumor virus mRNA's. J Virol (1981) 1.29
Negative regulation in correct tissue-specific expression of mouse mammary tumor virus in transgenic mice. Mol Cell Biol (1990) 1.23
Measles revaccination. Persistence and degree of antibody titer by type of immune response. Am J Dis Child (1978) 1.22
Discrete high molecular weight RNA transcribed from the long interspersed repetitive element L1Md. Nucleic Acids Res (1987) 1.17
Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies. Ann Rheum Dis (2004) 1.15
Factors associated with a malignant or benign course of multiple sclerosis. JAMA (1982) 1.12
Homeoproteins CDP and SATB1 interact: potential for tissue-specific regulation. Mol Cell Biol (1999) 1.10
Plasma exchange for acute attacks of CNS demyelination: Predictors of improvement at 6 months. Neurology (2009) 1.09
A longitudinal study of cytomegalovirus infection in human immunodeficiency virus type 1-seropositive homosexual men: molecular epidemiology and association with disease progression. J Infect Dis (1994) 1.09
A redundant nuclear protein binding site contributes to negative regulation of the mouse mammary tumor virus long terminal repeat. J Virol (1995) 1.07
In vitro transcription of the Bacillus subtilis phage phi 29 DNA by Bacillus subtilis and Escherichia coli RNA polymerases. Nucleic Acids Res (1984) 1.06
Molecular cloning and characterization of mouse mammary tumor proviruses from a T-cell lymphoma. J Virol (1986) 1.05
Detection of mouse mammary tumor virus RNA in BALB/c tumor cell lines of nonviral etiologies. J Virol (1978) 1.04
Mutational and functional analysis of the C-terminal region of the C3H mouse mammary tumor virus superantigen. J Virol (1998) 1.03
Isolated absence of nasal cilia: a case report. Ann Allergy (1984) 0.99
Mouse mammary tumor viruses with functional superantigen genes are selected during in vivo infection. Proc Natl Acad Sci U S A (1995) 0.99
CDP is a repressor of mouse mammary tumor virus expression in the mammary gland. J Virol (2000) 0.99
Onset symptoms as predictors of mortality and disability in multiple sclerosis. Acta Neurol Scand (1984) 0.98
Transient ischaemic attack: a common initial manifestation of cardiac myxomas. Eur Neurol (2001) 0.97
Exogenous mouse mammary tumor virus (MMTV) infection induces endogenous MMTV sag expression. Virology (1996) 0.94
Type B leukemogenic virus has a T-cell-specific enhancer that binds AML-1. J Virol (2001) 0.94
Predictors of clinical AIDS in young homosexual men in a high-risk area. Int J Epidemiol (1987) 0.94
Psychosocial predictors of gay men's AIDS risk-reduction behavior. Health Psychol (1991) 0.93
An association study of bipolar mood disorder (type I) with the 5-HTTLPR serotonin transporter polymorphism in a human population isolate from Colombia. Neurosci Lett (2000) 0.93
Proliferation centers in chronic lymphocytic leukemia: the niche where NF-kappaB activation takes place. Leukemia (2010) 0.93
Platelet activation In mice and human Helicobacter pylori infection. J Clin Invest (1997) 0.93
Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates. Transfusion (2005) 0.93
Factors associated with a rapid course of multiple sclerosis. Arch Neurol (1982) 0.93
Differential expression of poly(A)-adjacent sequences of mammary tumor virus RNA in murine mammary cells. Proc Natl Acad Sci U S A (1978) 0.92
Selection for c-myc integration sites in polyclonal T-cell lymphomas. J Virol (2002) 0.92
Atypical mycobacteria-induced cervical adenitis. Treatment by needle aspiration. Arch Otolaryngol Head Neck Surg (1988) 0.92
The c-myc locus is a common integration site in type B retrovirus-induced T-cell lymphomas. J Virol (2000) 0.91
"Abnormal" electrocardiograms in patients with cocaine-associated chest pain are due to "normal" variants. J Emerg Med (1994) 0.91
Sinus infection due to Eikenella corrodens. Arch Otolaryngol (1978) 0.91
Multiple sclerosis and age at migration. Am J Epidemiol (1978) 0.90
Underlying cause of death as recorded for multiple sclerosis patients: associated factors. J Chronic Dis (1983) 0.90
Major histocompatibility complex class II I-E-independent transmission of C3H mouse mammary tumor virus. J Virol (1996) 0.90
Transformation in Penicillium chrysogenum. Gene (1987) 0.90
Comparison of the growth properties in vitro and transplantability of continuous mouse mammary tumor cell lines and clonal derivatives. Cancer Res (1977) 0.89
Metastatic osteosarcoma presenting as a small-bowel polyp. A case report and review of the literature. Arch Pathol Lab Med (2000) 0.88
Red blood cell phenotypes in alpha-thalassemias in the Spanish population. Haematologica (1998) 0.88
Determinants of wound infections after surgery for breast cancer. Zentralbl Gynakol (2003) 0.88
Two populations with multiple sclerosis. Clinical and demographic characteristics. J Neurol (1981) 0.87
What retroviruses teach us about the involvement of c-Myc in leukemias and lymphomas. Leukemia (2002) 0.87
Detection of Enterocytozoon bieneusi in two human immunodeficiency virus-negative patients with chronic diarrhea by polymerase chain reaction in duodenal biopsy specimens and review. Clin Infect Dis (1998) 0.87
Strain-specific expression of spliced MMTV RNAs containing the superantigen gene. Virology (1997) 0.87
Lymphomas with acquired mouse mammary tumor virus proviruses resemble distinct prethymic and intrathymic phenotypes defined in vivo. J Immunol (1989) 0.86
Spontaneous regression of Merkel cell carcinoma of the skin. Br J Dermatol (1997) 0.86
Differential response of cultured mouse mammary cells of varying tumorigenicity to cytochalasin B. Cancer Res (1978) 0.86
Epidermolysis bullosa dystrophica of the larynx and trachea. Acute airway obstruction. Ann Otol Rhinol Laryngol (1981) 0.85
Influence of different indwelling lines on the measurement of blood cyclosporin A levels. Bone Marrow Transplant (1988) 0.85
Evidence for lower susceptibility to multiple sclerosis in Japanese-Americans. Am J Epidemiol (1977) 0.85
Otolaryngologic manifestations of the mucopolysaccharidoses. Ann Otol Rhinol Laryngol (1992) 0.85
Scanning and transmission electron microscopic aspects of the nasal acilia syndrome. Laryngoscope (1982) 0.84
IgM and IgG antibody responses after immunization of children with inactivated monovalent (A/New Jersey/76) and bivalent (A/New Jersey/76-A/Victoria/75) influenza virus vaccines. J Infect Dis (1977) 0.84
The relationship between T-cell levels and CMV infection in asymptomatic HIV-1 antibody-positive homosexual men. J Acquir Immune Defic Syndr (1993) 0.83
Transformation of Penicillium chrysogenum to sulfonamide resistance. Gene (1989) 0.83
Arytenoid dislocation and computed tomography. Arch Otolaryngol (1984) 0.83
Salvage chemotherapy with alternating MINE-ESHAP regimen in relapsed or refractory Hodgkin's lymphoma followed by autologous stem-cell transplantation. Ann Oncol (2009) 0.83
Thrombin facilitates primary platelet adhesion onto vascular surfaces in the absence of plasma adhesive proteins: studies under flow conditions. Haematologica (2000) 0.83
Expression of mouse mammary tumor virus superantigen mRNA in the thymus correlates with kinetics of self-reactive T-cell loss. J Virol (1999) 0.83
Supraglottitis and Hemophilus parainfluenzae: pathogenic potential of the organism. Ann Otol Rhinol Laryngol (1987) 0.82
Diabetic retinopathy. Nutr Hosp (2013) 0.81
Mortality in persons with multiple sclerosis in the Seattle and Los Angeles areas. JAMA (1981) 0.81
Latitude, migration, and the prevalence of multiple sclerosis. Am J Epidemiol (1977) 0.81
An MMTV integration site maps near the distal end of mouse chromosome 11. Mamm Genome (1997) 0.81
Tonsillitis due to neisseria meningitidis. Its treatment with rifampin. Arch Otolaryngol (1981) 0.81
Cys209 Ser mutation in the platelet membrane glycoprotein Ib alpha gene is associated with Bernard-Soulier syndrome. Br J Haematol (1994) 0.80
Sclerosing sweat duct carcinoma mimicking dermatofibroma. J Eur Acad Dermatol Venereol (1998) 0.80
Effect of topical anesthetics on ciliary activity of chicken embryo tracheal origin cultures. Study using total immersion and intratracheal injection. Ann Otol Rhinol Laryngol (1978) 0.80
Cytoskeletal reorganization after preparation of platelet concentrates, using the buffy coat method, and during their storage. Haematologica (1998) 0.80
Alterations in cytoskeletal organization and tyrosine phosphorylation in platelet concentrates prepared by the buffy coat method. Transfusion (2000) 0.80
Possible adverse reactions in sheep after vaccination with inactivated BTV vaccines. Vet Rec (2010) 0.80
Molecular characterization of a new family with alpha-thalassemia-1 (--MA mutation). Am J Hematol (1995) 0.80
Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trial with double randomization. J Clin Oncol (1998) 0.80
Self-expanding plastic stents for the treatment of post-operative esophago-jejuno anastomosis leak. A case series study. Rev Esp Enferm Dig (2010) 0.79
Patterns of CD4+ cell changes after HIV-1 infection indicate the existence of a codeterminant of AIDS. J Acquir Immune Defic Syndr (1988) 0.79
Demonstration of the adherence of Streptococcus pyogenes to the surface of human tonsillar tissue. Am J Otolaryngol (1980) 0.79
The endogenous Mtv-8 provirus resides within the V kappa locus. J Virol (1991) 0.79
Chromosomal localization of acquired MMTV proviral integration sites in T-cell lymphomas. Mamm Genome (1998) 0.79
Early vocal cord paralysis in olivopontocerebellar atrophy. J Neurol (1996) 0.79
Pilomatrixoma of the head and neck. Head Neck Surg (1984) 0.79
[Fusarium solani bronchopneumonia in a patient with acute myeloblastic leukemia]. Enferm Infecc Microbiol Clin (1990) 0.79
Studies on the megakaryocytes of a patient with the Bernard-Soulier syndrome. Br J Haematol (1990) 0.79
A Jerte valley cherry product provides beneficial effects on sleep quality. Influence on aging. J Nutr Health Aging (2013) 0.78